• News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Covaxin For Children

Covaxin Shows Robust Safety & Immunogenicity In Children 2-18 Years

Bharat Biotech International Limited (BBIL), a global developer of vaccines for infectious diseases, today announced that BBV152 (COVAXINÒ), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study.

Read More